These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 19572064)
21. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia. Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725 [TBL] [Abstract][Full Text] [Related]
22. Fibrinogen Seoul (FGG Ala341Asp): a novel mutation associated with hypodysfibrinogenemia. Song KS; Park NJ; Choi JR; Doh HJ; Chung KH Clin Appl Thromb Hemost; 2006 Jul; 12(3):338-43. PubMed ID: 16959688 [TBL] [Abstract][Full Text] [Related]
23. Novel fibrinogen mutation (gamma 313 Ser-->Asn) associated with hypofibrinogenemia in two unrelated families. Meyer M; Bergmann F; Brennan SO Blood Coagul Fibrinolysis; 2006 Jan; 17(1):63-7. PubMed ID: 16607083 [TBL] [Abstract][Full Text] [Related]
24. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization. Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560 [TBL] [Abstract][Full Text] [Related]
25. Hypofibrinogenemia due to novel 316 Asp --> Tyr substitution in the fibrinogen Bbeta chain. Brennan SO; Wyatt JM; May S; De Caigney S; George PM Thromb Haemost; 2001 Mar; 85(3):450-3. PubMed ID: 11307813 [TBL] [Abstract][Full Text] [Related]
26. Fibrinogen Guarenas, an abnormal fibrinogen with an Aalpha-chain truncation due to a nonsense mutation at Aalpha 467 Glu (GAA)-->stop (TAA). Marchi R; Carvajal Z; Meyer M; Soria J; Ruiz-Saez A; Arocha-Piñango CL; Weisel JW Thromb Res; 2006; 118(5):637-50. PubMed ID: 16406498 [TBL] [Abstract][Full Text] [Related]
27. A new type of congenital dysfibrinogen, fibrinogen Bremen, with an A alpha Gly-17 to Val substitution associated with hemorrhagic diathesis and delayed wound healing. Wada Y; Niwa K; Maekawa H; Asakura S; Sugo T; Nakanishi M; Auerswald G; Popp M; Matsuda M Thromb Haemost; 1993 Sep; 70(3):397-403. PubMed ID: 8259537 [TBL] [Abstract][Full Text] [Related]
28. Fibrinogen Otago: a major alpha chain truncation associated with severe hypofibrinogenaemia and recurrent miscarriage. Ridgway HJ; Brennan SO; Faed JM; George PM Br J Haematol; 1997 Sep; 98(3):632-9. PubMed ID: 9332319 [TBL] [Abstract][Full Text] [Related]
29. A three-dimensional consideration of variant human fibrinogens. Everse SJ; Spraggon G; Doolittle RF Thromb Haemost; 1998 Jul; 80(1):1-9. PubMed ID: 9684777 [TBL] [Abstract][Full Text] [Related]
30. A novel Asp344Val substitution in the fibrinogen gamma chain (fibrinogen Caen) causes dysfibrinogenemia associated with thrombosis. Robert-Ebadi H; Le Querrec A; de Moerloose P; Gandon-Laloum S; Borel Derlon A; Neerman-Arbez M Blood Coagul Fibrinolysis; 2008 Oct; 19(7):697-9. PubMed ID: 18832913 [TBL] [Abstract][Full Text] [Related]
31. Fibrinogen Krakow: a novel hypo/dysfibrinogenemia mutation in fibrinogen gamma chain (Asn325Ile) affecting fibrin clot structure and function. Undas A; Zdziarska J; Iwaniec T; Stepien E; Skotnicki AB; de Moerloose P; Neerman-Arbez M Thromb Haemost; 2009 May; 101(5):975-6. PubMed ID: 19404553 [No Abstract] [Full Text] [Related]
32. Severe hypodysfibrinogenemia in compound heterozygotes of the fibrinogen AalphaIVS4 + 1G>T mutation and an AalphaGln328 truncation (fibrinogen Keokuk). Lefebvre P; Velasco PT; Dear A; Lounes KC; Lord ST; Brennan SO; Green D; Lorand L Blood; 2004 Apr; 103(7):2571-6. PubMed ID: 14615374 [TBL] [Abstract][Full Text] [Related]
33. A frameshift mutation in Exon V of the A alpha-chain gene leading to truncated A alpha-chains in the homozygous dysfibrinogen Milano III. Furlan M; Steinmann C; Jungo M; Bögli C; Baudo F; Redaelli R; Fedeli F; Lämmle B J Biol Chem; 1994 Dec; 269(52):33129-34. PubMed ID: 7806542 [TBL] [Abstract][Full Text] [Related]
34. Dysfibrinogen Kagoshima with the amino acid substitution gammaThr-314 to Ile: analyses of molecular abnormalities and thrombophilic nature of this abnormal molecule. Niwa K; Mimuro J; Miyata M; Sugo T; Ohmori T; Madoiwa S; Tei C; Sakata Y Thromb Res; 2008; 121(6):773-80. PubMed ID: 17854865 [TBL] [Abstract][Full Text] [Related]
35. [Usefulness of a single radial immunodiffusion method for the immediate diagnosis of abnormal fibrinogenemia in the laboratory]. Yoshika M; Komiyama Y; Terauchi S; Teraoka A; Munakata M; Yasuda K; Amakawa R; Masaki H; Takahashi H Rinsho Byori; 2008 May; 56(5):379-82. PubMed ID: 18546886 [TBL] [Abstract][Full Text] [Related]
36. Novel Aalpha chain truncation (fibrinogen Perth) resulting in low expression and impaired fibrinogen polymerization. Homer VM; Mullin JL; Brennan SO; Barr A; George PM J Thromb Haemost; 2003 Jun; 1(6):1245-50. PubMed ID: 12871326 [TBL] [Abstract][Full Text] [Related]
37. Adjacent substitutions (γ352Gly→Cys and 353Thr→Pro) in fibrinogen Ilam cause diminished γ chain expression. Brennan SO; Oliver J; Davis RL Thromb Haemost; 2011 Feb; 105(2):379-81. PubMed ID: 21057694 [No Abstract] [Full Text] [Related]
38. The dimeric Aalpha chain composition of dysfibrinogenemic molecules with mutations at Aalpha 16. Meh DA; Siebenlist KR; Galanakis DK; Bergtrom G; Mosesson MW Thromb Res; 1995 Jun; 78(6):531-9. PubMed ID: 15714754 [TBL] [Abstract][Full Text] [Related]
39. Exon skipping and aberrant signal peptide cleavage produce novel fibrinogen with an Aα chain lacking the first 42 residues. Brennan SO; Laurie AD; McRae S Thromb Haemost; 2016 Aug; 116(3):581-5. PubMed ID: 27277572 [No Abstract] [Full Text] [Related]
40. Fibrinogen Poissy I: a new case of the A alpha Arg 16His fibrinogen variant. Mathonnet F; Guillon L; Detruit H; Van Amerongen G; Denninger MH; Giudicelli Y; de Mazancourt P Blood Coagul Fibrinolysis; 1997 Oct; 8(7):441-4. PubMed ID: 9391726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]